You are here:

melatonin 2mg prolonged-release tablets (Circadin)


In the absence of a submission from the holder of the marketing authorisation.

melatonin prolonged-release tablets (Circadin) are not recommended for use within NHSScotland as monotherapy for the short-term treatment of primary insomnia characterized by poor quality of sleep in patients who are aged 55 or over.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.

Drug Details

Drug Name: melatonin 2mg prolonged-release tablets (Circadin)
SMC Drug ID: 500/08
Manufacturer: Lundbeck Ltd
Indication: for the short-term treatment of primary insomnia
BNF Category:
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 11 August 2008